These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 21931545)

  • 1. Disruption of TLR3 signaling due to cleavage of TRIF by the hepatitis A virus protease-polymerase processing intermediate, 3CD.
    Qu L; Feng Z; Yamane D; Liang Y; Lanford RE; Li K; Lemon SM
    PLoS Pathog; 2011 Sep; 7(9):e1002169. PubMed ID: 21931545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enterovirus 68 3C protease cleaves TRIF to attenuate antiviral responses mediated by Toll-like receptor 3.
    Xiang Z; Li L; Lei X; Zhou H; Zhou Z; He B; Wang J
    J Virol; 2014 Jun; 88(12):6650-9. PubMed ID: 24672048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disruption of innate immunity due to mitochondrial targeting of a picornaviral protease precursor.
    Yang Y; Liang Y; Qu L; Chen Z; Yi M; Li K; Lemon SM
    Proc Natl Acad Sci U S A; 2007 Apr; 104(17):7253-8. PubMed ID: 17438296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seneca Valley Virus Suppresses Host Type I Interferon Production by Targeting Adaptor Proteins MAVS, TRIF, and TANK for Cleavage.
    Qian S; Fan W; Liu T; Wu M; Zhang H; Cui X; Zhou Y; Hu J; Wei S; Chen H; Li X; Qian P
    J Virol; 2017 Aug; 91(16):. PubMed ID: 28566380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cleavage of the adaptor protein TRIF by enterovirus 71 3C inhibits antiviral responses mediated by Toll-like receptor 3.
    Lei X; Sun Z; Liu X; Jin Q; He B; Wang J
    J Virol; 2011 Sep; 85(17):8811-8. PubMed ID: 21697485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Limited suppression of the interferon-beta production by hepatitis C virus serine protease in cultured human hepatocytes.
    Dansako H; Ikeda M; Kato N
    FEBS J; 2007 Aug; 274(16):4161-76. PubMed ID: 17651439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of HAV and HCV infections in vivo and in vitro reveals distinct patterns of innate immune evasion and activation.
    Colasanti O; Burm R; Huang HE; Riedl T; Traut J; Gillich N; Li TF; Corneillie L; Faure-Dupuy S; Grünvogel O; Heide D; Lee JY; Tran CS; Merle U; Chironna M; Vondran FFW; Esser-Nobis K; Binder M; Bartenschlager R; Heikenwälder M; Meuleman P; Lohmann V
    J Hepatol; 2023 Sep; 79(3):645-656. PubMed ID: 37121436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The coxsackievirus B 3C protease cleaves MAVS and TRIF to attenuate host type I interferon and apoptotic signaling.
    Mukherjee A; Morosky SA; Delorme-Axford E; Dybdahl-Sissoko N; Oberste MS; Wang T; Coyne CB
    PLoS Pathog; 2011 Mar; 7(3):e1001311. PubMed ID: 21436888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TLR3/TRIF signalling pathway regulates IL-32 and IFN-β secretion through activation of RIP-1 and TRAF in the human cornea.
    Park GB; Hur DY; Kim YS; Lee HK; Yang JW; Kim D
    J Cell Mol Med; 2015 May; 19(5):1042-54. PubMed ID: 25754842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis A virus 3C protease cleaves NEMO to impair induction of beta interferon.
    Wang D; Fang L; Wei D; Zhang H; Luo R; Chen H; Li K; Xiao S
    J Virol; 2014 Sep; 88(17):10252-8. PubMed ID: 24920812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SARS-CoV-2 NSP7 inhibits type I and III IFN production by targeting the RIG-I/MDA5, TRIF, and STING signaling pathways.
    Deng J; Zheng Y; Zheng SN; Nan ML; Han L; Zhang J; Jin Y; Pan JA; Gao C; Wang PH
    J Med Virol; 2023 Mar; 95(3):e28561. PubMed ID: 36755358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kaposi sarcoma-associated herpesvirus degrades cellular Toll-interleukin-1 receptor domain-containing adaptor-inducing beta-interferon (TRIF).
    Ahmad H; Gubbels R; Ehlers E; Meyer F; Waterbury T; Lin R; Zhang L
    J Biol Chem; 2011 Mar; 286(10):7865-7872. PubMed ID: 21212282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SARS-CoV-2 ORF9b antagonizes type I and III interferons by targeting multiple components of the RIG-I/MDA-5-MAVS, TLR3-TRIF, and cGAS-STING signaling pathways.
    Han L; Zhuang MW; Deng J; Zheng Y; Zhang J; Nan ML; Zhang XJ; Gao C; Wang PH
    J Med Virol; 2021 Sep; 93(9):5376-5389. PubMed ID: 33913550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Porcine Epidemic Diarrhea Virus 3C-Like Protease Regulates Its Interferon Antagonism by Cleaving NEMO.
    Wang D; Fang L; Shi Y; Zhang H; Gao L; Peng G; Chen H; Li K; Xiao S
    J Virol; 2016 Feb; 90(4):2090-101. PubMed ID: 26656704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enterovirus 2Apro targets MDA5 and MAVS in infected cells.
    Feng Q; Langereis MA; Lork M; Nguyen M; Hato SV; Lanke K; Emdad L; Bhoopathi P; Fisher PB; Lloyd RE; van Kuppeveld FJ
    J Virol; 2014 Mar; 88(6):3369-78. PubMed ID: 24390337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing activity of Hepatitis A virus 3C protease using a cyclized luciferase-based biosensor.
    Zhou J; Wang D; Xi Y; Zhu X; Yang Y; Lv M; Luo C; Chen J; Ye X; Fang L; Xiao S
    Biochem Biophys Res Commun; 2017 Jul; 488(4):621-627. PubMed ID: 28501618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Foot-and-mouth disease virus 3C protease cleaves NEMO to impair innate immune signaling.
    Wang D; Fang L; Li K; Zhong H; Fan J; Ouyang C; Zhang H; Duan E; Luo R; Zhang Z; Liu X; Chen H; Xiao S
    J Virol; 2012 Sep; 86(17):9311-22. PubMed ID: 22718831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TNF receptor-associated factor-1 (TRAF1) negatively regulates Toll/IL-1 receptor domain-containing adaptor inducing IFN-beta (TRIF)-mediated signaling.
    Su X; Li S; Meng M; Qian W; Xie W; Chen D; Zhai Z; Shu HB
    Eur J Immunol; 2006 Jan; 36(1):199-206. PubMed ID: 16323247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Viral protease cleavage of MAVS in genetically modified mice with hepatitis A virus infection.
    Sun L; Feng H; Misumi I; Shirasaki T; Hensley L; González-López O; Shiota I; Chou WC; Ting JP; Cullen JM; Cowley DO; Whitmire JK; Lemon SM
    J Hepatol; 2023 Feb; 78(2):271-280. PubMed ID: 36152761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of IRF-3 and IRF-7 phosphorylation following activation of the RIG-I pathway.
    Paz S; Sun Q; Nakhaei P; Romieu-Mourez R; Goubau D; Julkunen I; Lin R; Hiscott J
    Cell Mol Biol (Noisy-le-grand); 2006 May; 52(1):17-28. PubMed ID: 16914100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.